 |
IO Biotech
Last updated: October 11, 2024
CEO Mai-Britt Zocca
Denmark | Funding: $175M (+)
Website: https://www.iobiotech.com/
IO Biotech ApS is a clinical stage biotech company developing disruptive immune therapies i.e. checkpoint/cancer vaccines.
Website: https://www.iobiotech.com/
IO Biotech ApS is a clinical stage biotech company developing disruptive immune therapies i.e. checkpoint/cancer vaccines.
